InstructorRoyed Training
TypeOnline Course
Student Enrolled2
Price$490 USD / 24500 INR.
Buy NowBook Now
Loading
free resources at royed training
Loading
Latam drug regulatory affairs

Introduction

Course Type

Course Duration

Feature

Eligibility

Who should attend

Certification

Course Deliverable

Related Courses

About RA

Latam Drug Regulatory Affairs

This drug regulatory affairs course provides training on drug registration and regulation in Latin American – LATAM countries. The course covers the Drug Regulatory requirements across Latin America including Columbia, Peru, Brazil, Mexico, Argentina, Uruguay, Paraguay, Venezuela, Ecuador, Central America, Chile. The course provides training on marketing authorization filing in Latin American Countries.

LATAM DRA course covers recent regulations, marketing authorization procedure, country specific Common Technical Documents, guidelines and dossier preparation. Moreover course focus on the regulatory affairs strategic planning for marketing authorization for different class of pharmaceutical, biopharmaceutical. Hence, this course is vastly useful for those who want to know or already working in regulatory affairs. Above all, this course will help them to enhance competency to handle LATAM pharmaceutical Marketing Authorization Application  (MAA) effectively.

The course is designed to challenge students and Professionals to apply what they have learned through the use of interactive exercises, reflection questions, and a final assessment at the end of the course.

Above all, the course is based on convenient online self paced learning. Hence, it provides flexibility to undergo training from any country across the globe. It also allows the user to stop and start at their leisure.

Course Title: Advance Certification in LATAM Drug Regulatory Affairs
Course Code: RYD-041

Online distance learning course. Therefore the course can be accessed online across anywhere 24×7.

1 Month

This LATAM drug regulatory affairs online course utilizes interactive learning tools to guide each participant through to understand of the regulatory process of in Latin American countries. Hence, this online certification course will focus on understanding regulatory affairs strategic management skills which is required for effective functioning as regulatory personnel. Indeed, advance simulation in the course will challenge students to apply what they have learned from the course. In addition, there are advance learning tools like interactive exercises, reflection questions, expert live chat which makes the course very interesting.

Key features of the course

  • Orientation to practical understanding in the entire drug regulation, registration procedure of Latin American countries. Moreover, course also focus on Common Technical Documents, guidelines and drug dossier preparations. Above all, course explains various marketing authorization strategic pathways. Hence, this course helps to enhance the regulatory strategic decision making skill.
  • The course extensively covers marketing authorization requirements for full application, verification pathway and abridged pathway.
  • This training program has advance sessions on CMC preparation, Stability Study, Drug Master File Preparation, Site Master File Preparation, Good Manufacturing Practices modules. Above all, course focus on variation requirement specific to LATAM countries.
  • The course is self paced. Hence, course can be accessed 24×7, anytime, anywhere across the globe.
  • Moreover, students can download the course material hand out by login to dashboard. Hence, it helps them to study offline even after completion of the course.
  • Final examination is online. Hence, student can attend the final certification examination at own convenient date and time.

Graduation in any discipline. Even the final year student can join the course.

Who should attend

  • Course is ideal for the Freshers and beginners.
  • Similarly, course provide advanced learning for those who want to know about the LATAM drug regulation and registration process.
  • So, this course suits to those, who want to enhance knowledge about the LATAM Drug Regulatory Affairs.
  • Certainly, LATAM Drug Regulatory Affairs course is ideal for Business Development, Regulatory Affairs, IPR, strategic management professionals. In short, course will provide 360 degree knowledge about the registration, regulation, strategic pathways of the pharmaceuticals in Latin American countries.

 Certificate will be provided at the end of the successful completion of the course.

  1. Attend the course 24×7 by login to your dashboard. So, you can attend lectures, simulation, self assessment tests and final certification examination.
  2. You will also eligible to receive the course study modules, which you can download by login to your course page.

Few of the similar courses

Latin America is generally understood to consist of the entire continent of South America in addition to Mexico, Central America, and the islands of the Caribbean.

North And Central America

Belize, Costa Rica, El Salvador, Guatemala, Honduras, Mexico, Nicaragua, Panama.

South America

Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana (département of France), Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela.

Caribbean countries

Countries: Cuba, Dominican Republic, Haiti.
dependencies and constituent entities: Guadeloupe, Martinique, Puerto Rico, Saint-Barthélemy, Saint-Martin.

Learn more about the Latin American Countries >> Learn more

About regulatory affairs job>> Learn here

Regulatory Landscape – Latin America

Here are three important points to note.

  • First of all, LATAM region does not have a centralized or harmonized procedure for drug registration. Hence, regulatory professionals need to learn each and every country regulation separately.
  • However, adoption or adaptation of guidelines from ICH countries have helped to harmonize the requirements for the development and approval of new medicines.
  • Thirdly, LATAM countries have been aligning regionally and reinforcing harmonization, through initiatives of the Pan American Health Organization (PAHO) via the Pan American Network for Drug Regulatory Harmonization (PANDRH).

Supranational key regulating bodies in Latin America

  • PAHO/OPS – Pan American Health Organization.
  • PANDRH/Red PARF – Pan American Network for Drug Regulatory Harmonization.
  • WHO/OMS – World Health Organization.
  • ICH – International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, Global Cooperation Groups.

Section 1Fundamental Understanding on Drug Discovery and Development
Lecture 1Introduction to Pharmaceutical R&D | Drug Discovery Development Process
Lecture 2Investigational New Drug Application (INDA)
Lecture 3New Drug Application (NDA) 
Lecture 4Basic concept and understanding of the Generic Drug
Lecture 5Abbreviated New Drug Application (ANDA) 
Lecture 6Handling of orange book
Lecture 7Complete Response Letter | Key understanding | Management and Action Plan
Lecture 8USFDA expedited programs
Lecture 9505(j) ANDA, 505(b)(2) NDA, 505(b)(1) NDA
Lecture 10Authorized Generics: Key Understanding
Lecture 11Exploratory IND Vs. Traditional IND
Lecture 12Orphan Drug Designation 
Lecture 13Advance Learning on 505B2 Pathway
Lecture 14Chemistry, Manufacturing & Controls 
Lecture 15Patent & Exclusivity - Strategic Understanding | Patent Restoration| Orphan Drug Exclusivity (ODE) | NCE & NCI Exclusivity | GAIN Exclusivity | Pediatric Exclusivity | 180 days exclusivity
Lecture 16Clinical Trials Terminologies 
Lecture 17Clinical Trial Protocol Writing
Lecture 18Ethics in Clinical Research
Lecture 19Informed Consent | Practical Training on preparing ICF | Ready Templates
Lecture 20Review on Drug Discovery and Development 
Section 2Latam Regulatory Requirements and Strategic Planning for Marketing Authorization Application
Lecture 21Different Business Regions
Lecture 22Introduction to Latam Pharma Market
Lecture 23Drug Registration and Regulation in Argentina 
Lecture 24Drug Registration and Regulation in Bolivia
Lecture 25Drug Registration and Regulation in Brazil 
Lecture 26Drug Registration and Regulation in CHILE
Lecture 27Drug Registration and Regulation in Colombia
Lecture 28Drug Registration and Regulation in Mexico
Lecture 29Central America Drug Regulatory Affairs | Panama, Costa Rica, Guatemala, El Salvador, Honduras, Dominican Republic | RTCA guideline [2022]
Lecture 30Drug Registration and Regulation in El Salvador
Lecture 31Drug regulation and registration in Peru
Lecture 32Honduras Drug Registration Guideline and Fact Files
Lecture 33RTCA - Central America Guideline Recent Update 2022
Section 3Plant Certification| Inspections | GMP requirements
Lecture 34Certification Pharmaceutical Companies / Plants
Lecture 35G1 Lecture Premises & Plant Layout Designing
Lecture 36G2 Lecture Sanitation and Hygiene
Lecture 37G3 Lecture Equipment Modules
Lecture 38G4 Lecture Production Modules
Lecture 39G5 Lecture Documentation
Lecture 40G6 Lecture Quality Control
Lecture 41G7 Lecture Product Complaint
Lecture 42G8 Lecture Storage Module
Lecture 43ISO and ISO Audits
Lecture 44Pharmaceutical SOPs Management from regulatory perspective
Lecture 45Introduction to Certificate of Pharmaceutical Product | Types of CoPP | List of Countries / Regulatory Authorities who requires CoPP | CoPP as a part of generic market expansion planning 
Lecture 46WHO-GMP Certification Scheme 
Lecture 47Template of Certificate of Pharmaceutical product | Key observations and points to note while working on CoPP
Section 4Submission Dossier Preparation and Filing
Lecture 48Introduction to Common Technical Document (CTD)
Lecture 49Advance Practical Training on Dossier Preparation focusing on drug registration in export countries 
Lecture 50Chemistry, Manufacturing & Controls 
Lecture 51Fundamental of CMC | Detailed understanding of CMC section writing | Important Points regarding CMC | Drug Product and Drug Substance | Excipient, FP, Analysis and Stability Study Requirements
Lecture 52ICH Q1 : Stability Guideline | Matrixing | Bracketing
Lecture 53ICH Q2 : Analytical Validation 
Lecture 54ICH Q3 : Impurities
Lecture 55Rest of ICH Q Family Guidelines
Lecture 56CMC Dossier & Compliance Management
Lecture 57Introduction to Electronic Common Technical Document (ECTD)
Lecture 58Key Consideration for Drug Master File Preparation and Submission 
Lecture 59Practical Understanding on Drug Master File Preparation and Submission
Lecture 60Associated Learning: Site Master File - Detailed Understanding 
Lecture 61Drug Master File - Global Perspective [Across Different Regions]
Lecture 62Importance of effective dossier management
Lecture 63Discussion on 85 common deficiencies in CTD submission dossier
Section 5Stability Study
Lecture 64Modules on Stability Study : Stability Study - Fundamental Understanding | Interchangebility | Reports | API & FPP Stability Study
Lecture 65Climate Zone
Lecture 66Stability Zone Finder
Lecture 67Stability Studies - Case Based Discussion
Lecture 68Stability Data for Zone IV countries
Lecture 69Accelerated and intermediate testing conditions
Lecture 70Long Term Stability Testing Requirements
Lecture 71Stability Study Protocol Development - Dosage form: Capsule
Lecture 72Stability Data Sheet
Lecture 73Stability Testing for dossier submission
Lecture 74Testing Frequency
Lecture 75Bracketing
Lecture 76Matrixing
Section 6PKPD in Drug Discovery | PK-PD trial | Understanding PKPD from regulatory perspective in drug approval process
Lecture 77PKPD in Drug Discovery | PK-PD trial | Understanding PKPD from regulatory perspective in drug approval process
Lecture 78Bioequivalence Study | Study design | Different types of BE Studies
Lecture 79Bioequivalence Study | Study design | Parallel Study | Crossover study design | Other alternative study designs | Blood Sampling Planning  | Analyte | Bioanalytical Methods Validation  | Statistical Model  | Ln Transformation  | Dose normalisation | Confidence interval acceptance criteria
Lecture 80Biopharmaceutical Classification System (BCS) | Types | Biowaivers | BCS tool for drug development and regulatory submission 
Lecture 81Bioequivalence Study - Discussion - Timeline of stability study and bioequivalence study 
Lecture 82Bioequivalence Study - Discussion - Dissolution Testing
Lecture 83Bioequivalence Study - Generic Approval and Additives Labeling Requirements 
Section 7Variation Management
Lecture 84Introduction to Variation Management | Reasons for Variation | Working in Variation Department 
Lecture 85Variation Classification | Basis of Classification | US and EU Variation Classification | Other region variation guideline.
Section 8Quality issues, Warning Letter, CAPA and Data Integrity
Lecture 86Quality Risk Management | ICH Q9 | ISO 14971 | Principle of Risk Management 
Lecture 87Data Integrity issues in Pharmaceutical Industry : Detailed Understanding 
Lecture 88Establishment Inspection Report | 483 Observations | USFDA Warning Letter | Handling of FDA inspection | Closing of Warning Letter 
Lecture 89Electronic Batch Record for effective compliance management | Key Understanding | Functionalities | Importance in managing data integrity
Lecture 90RTQs | Response to Queries | How to handle Regulatory Queries